While protein biomarkers such as Krebs von den Lungen 6 and surfactant protein D are unable to distinguish IPF from CTD-ILD, cellular biomarkers of immune activation may more accurately predict CTD-ILD. Here, MUC1 is linked to interstitial lung disease.